Peptide Therapeutics CDMO Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

Peptide Therapeutics CDMO Market: By Service (Peptide API Manufacturing, Drug Product/Fill-Finish, Process Development, Analytical & QC); Synthesis Technology (Solid-Phase Peptide Synthesis, Liquid-Phase Peptide Synthesis, Hybrid/Recombinant, Continuous Flow); Scale (Preclinical & Clinical, Commercial); Application (Metabolic/GLP-1, Oncology, Infectious Disease, Rare Disease, Cosmetic & Other); End User (Large Pharma, Emerging Biopharma, Generic Manufacturers)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035

The peptide therapeutics CDMO market is estimated at USD 4.5 billion in 2025 and is projected to reach USD 20 billion by 2035, growing at a CAGR of 16.2% over the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 10-Sep-2026  |  Format:  |  Report ID: AA09261985